Elanco Animal Health Inc
SWB:5EA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Elanco Animal Health Inc
SWB:5EA
|
US |
|
Brundage-Bone Concrete Pumping Holdings Inc
NASDAQ:BBCP
|
US |
|
C
|
Carrefour SA
BMV:CAN
|
FR |
|
C
|
Croda International PLC
F:6CMB
|
UK |
|
T
|
Transgene SA
F:TGNA
|
FR |
|
Charter Communications Inc
NASDAQ:CHTR
|
US |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
First National of Nebraska Inc
OTC:FINN
|
US |
|
N
|
Northrop Grumman Corp
F:NTH
|
US |
|
Rightscorp Inc
OTC:RIHT
|
US |
|
Calida Holding AG
SIX:CALN
|
CH |
|
G
|
Galp Energia SGPS SA
XMUN:GZ5
|
PT |
Wall St Price Targets
5EA Price Targets Summary
Elanco Animal Health Inc
According to Wall Street analysts, the average 1-year price target for 5EA is 26.46 EUR with a low forecast of 20.14 EUR and a high forecast of 29.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5EA's stock price target?
Price Target
26.46
EUR
According to Wall Street analysts, the average 1-year price target for 5EA is 26.46 EUR with a low forecast of 20.14 EUR and a high forecast of 29.14 EUR.
What is the Revenue forecast for Elanco Animal Health Inc?
Projected CAGR
4%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Elanco Animal Health Inc?
Projected CAGR
5%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 7 years is 5%.
What is the Operating Income forecast for Elanco Animal Health Inc?
Projected CAGR
23%
Over the last 11 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 8 years is 23%.
